Exploring the Utilization of Tampon-Derived Vaginal Fluids for Early Detection of Endometrial Cancer
ISEF · 2026 Translational Medical Science
Overview
Introduction: Endometrial Cancer (EC), the most common and deadliest gynecological cancer in the U.S., has seen a steady rise in incidence and mortality since 2003 across all races. When identified early, 5-year survival for patients is 95%, but drops to <15% upon metastasis. Despite this, there is no standardized screening method for EC, highlighting the need for novel, non-invasive detection strategies. This study explores the ability of molecular analyses of tampon-derived vaginal fluids to detect EC. Methods: Tampon samples were collected from 20 women presenting for suspicion of EC at the Gynecologic Oncology clinic at the University of Alabama at Birmingham and were consented under a pre-approved translational research IRB. i) 10 samples (five benign, five cancerous) underwent mass spectrometry-based proteomics. ii) The remaining 10 cancerous samples underwent a modified gDNA isolation protocol for future qPCR experiments to detect EC-associated mutational signatures using gene-specific primers. iii) RenCa-Luc gDNA was diluted (1, 2, 5, 10, 20, 50, 100 ng) and used in SYBR Green qPCR with an 18S rRNA primer set. Results: i) Proteomic analysis revealed differentiation between the protein profile of benign and cancerous samples. ii) The average gDNA yield was 3.29 µg with purity ratios (260/280=2.01 and 260/230=1.95) sufficient for future molecular analyses. iii) qPCR amplification curves were sigmoidal, and non-template controls confirmed the absence of contamination. The standard curve had a coefficient of determination of 0.993 and an efficiency of 90.8%. Conclusion: This exploratory study has demonstrated the potential for a non-invasive, tampon-based sampling method to detect EC early through proteomic and genomic analysis.
Competition history
- ISEF 2026
Resources
Related projects
ISEF · 2023
Non-Invasive Pre-Screening Approach for Early Detection of the Human Papillomavirus (HPV) to Aid in Cervical Cancer Prevention in Underrepresented Demographics
ISEF · 2024
Gyno-Genix: A Quadrupled Biosensor for the Early Screening of Multiple Gynecological Problems
ISEF · 2023
Ovydrome's Catch: A Biosensor for the Early Detection of Polycystic Ovarian Syndrome With and Approach to Prevent Further Gynecological Cancers
ISEF · 2018
Innovative Carbon Nanotube Based Microsensor for Early Diagnosis of Ovarian Cancer
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair